Delivery Order SPE2DR25D2100-SPE2DR26FA0HX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,330.42 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. This non-competitive delivery order, issued on November 24, 2025, represents a firm fixed-price transaction with an ultimate completion date of November 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,002.34 to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial with diluents. This contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vivitrol is a medication used in the treatment of opioid and alcohol use...
- The Defense Logistics Agency awarded a $12,655.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Vivitrol 380 mg vial-diluents, with completion scheduled for December 12, 2025. This non-set-aside contract will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran...
- The Defense Logistics Agency has awarded a delivery order valued at $40,167.61 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials and diluents. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 10, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a single transaction under a larger contract vehicle supporting the federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,730.90 on October 27, 2025, for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 28, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $6,330.42 to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial-diluents, with an ultimate completion date of October 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at the awardee's corporate headquarters in Conshohocken, Pennsylvania. Vivitrol is a medication used for opioid use disorder treatment, and this delivery order represents a specific pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,154.63 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed price, competitively awarded contract with no set-aside designation. The contract was awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vivitrol is a medication used primarily for opioid use...
- The Defense Logistics Agency awarded a $15,037.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. The contract, awarded on November 28, 2025, with an ultimate completion date of December 1, 2025, represents a non-competed delivery order under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order valued at $2,505.42 to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial-diluents, with an ultimate completion date of November 17, 2025. This firm fixed-price delivery order, awarded on November 14, 2025, represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vials with diluents valued at $1,055.07 under a firm fixed-price contract. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by December 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Vivitrol is an extended-release injectable medication used in opioid...
- SPE2DR25D2100Indefinite Delivery Contract
- SPE2DR25D2100-SPE2DR26FA0HXDelivery Order
The Defense Logistics Agency awarded a $6,650.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials and diluents. This non-competitive, non-set-aside order was awarded on December 1, 2025, with an ultimate completion date of December 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vivitrol is a medication used in the treatment of alcohol and opioid use disorders, representing a specialized pharmaceutical product within the company's broader federal medical supply portfolio. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen, a major pharmaceutical distributor and critical federal healthcare vendor, utilizes this comprehensive IDC to supply military and veteran healthcare systems with an extensive range of medications and medical supplies across multiple therapeutic domains. The company's federal contract portfolio demonstrates consistent capability to meet DLA procurement requirements through competitive awards of varying scales, positioning it as a key supplier for military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 11/30/25 |